Biotechnology & Medical Research
Chiome Bioscience Inc <4583.T>:Says 8 employees took up the offer of the early-retirement program announced on Feb. 12.
Medical&Biological Laboratories Co Ltd:To takeover phage display technology used antibody production business from its wholly owned subsidiary which is engaged in antibody related research and consignment research, for 1 yen, on May 11.
Anhui Anke Biotechnology (Group) Co Ltd:Says to merge a wholly owned Anhui-based pharmaceutical subsidiary.Says subsidiary to be dissolved after merger.
Human Metabolome Technologies Inc:Says the co decides to cease its temporary employee placement business, with effective date on March 31.
Veloxis Pharmaceuticals A/S:Says has decided to close its office in Hørsholm, Denmark, and move all activities to the U.S. where most of the company’s current activities is already located.The process is expected to be completed during H2 2016.
EPS Holdings Corporation:Says after subsidiary Sogo Rinsho Holdings wholly owns subsidiary EP-Mint Co., Ltd, EP-Mint Co., Ltd to merge Sogo Rinsho Science Co.,Ltd., which wholly owned by Sogo Rinsho Holdings.Says Sogo Rinsho Science Co.,Ltd to be dissolved after merger.Planned effective May 1.
Chiome Bioscience Inc:To offer an early-retirement program to 60 employees.Offering time from middle May.The company expects 11 employees to take up the offer.Says the employees who take up the offer will retire on June 30.The company will provide retirement payment to the retiring employees.
Ina Research announces result of early-retirement program and expects extraordinary loss for FY 2016
Ina Research Inc:Says 38 employees took up the offer of the early-retirement program.Effective date of retirement is Feb. 20, 2016.A premium will be added to the normal retirement allowance of eligible applicants.Says eligible applicants will also have the option to receive job-placement assistance.Expected extraordinary loss of about 70 mln yen for FY ending March 2016.
Addex Therapeutics:Moves R&D operations to Geneva's Campus Biotech.